By Roz Sweeney, Ph.D. Nerac Analyst, Healthcare payers, both in the United States and Europe, have been striving to reduce costs in recent years, and this trend is expected to continue. To address this emphasis on cost-reduction, medical device companies are becoming increasingly interested in the market for technologies that reduce costs to the overall healthcare […]
By Roz Sweeney, Ph.D. Nerac Analyst,
Comprehensive evaluations of the clinical and technical literature serve a variety of purposes for medical device companies.
Issue: The client, a major cardiovascular stent company, wanted to ensure proactively that their intra-aortic balloon pump (IABP) catheters would comply with new EU regulations. Read more.